The European Medicines Agency (EMA), which coordinates and supervises new treatments in the European Union, announced Monday that it could vote on the Moderna vaccine during the day. Initially, his findings were not to be made public until Wednesday. “Today there is a meeting of the EMA’s Committee for Medicinal Products for Human Use (CHMP) to discuss the Moderna vaccine,” the European regulator said in a statement.
A new press release could be issued during the day “in case the CHMP reaches a decision during today’s meeting”. Otherwise, the committee would meet again on Wednesday. The EMA authorized on December 21 the vaccine against the Covid-19 Pfizer / BioNTech, for which the European Commission immediately gave the green light, and was to pronounce on January 6 on that of Moderna.
Storage at – 20 ° C
The Moderna vaccine is taken in two doses, a few weeks apart, like the Pfizer / BioNTech vaccine. But Moderna’s formula can be stored at – 20 ° C, and not – 70 ° C as for the remedy from Pfizer, which forced the group to develop specific containers for transport. The American Medicines Agency (FDA) announced on December 18 that it had granted this American laboratory an emergency authorization, a week after having done the same with that of Pfizer and BioNTech. The EMA headquarters moved from London to Amsterdam as a consequence of Brexit.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
